Edited By: Dr Robert J. Boyle and Prof Mohamed H. Shamji
Journal list menu
Clinical & Experimental Allergy is the official Journal of the British Society for Allergy & Clinical Immunology, publishing clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field.
On the Cover
Articles
Cochrane Corner: Pharmacological Treatment of Gastro‐Oesophageal Reflux in Children
-  10 October 2024
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab
-  10 October 2024
Graphical Abstract
This study identifies two distinct subgroups of patients with severe eosinophilic asthma who respond differently to mepolizumab. Cluster analysis reveals that patients with a family history of asthma, positive skin prick tests and higher baseline lung function have better treatment outcomes, highlighting the value of personalised treatment strategies.
Adrenaline Auto‐Injectors for Preventing Fatal Anaphylaxis
-  9 October 2024
Graphical Abstract
During 35 years of increasing Adrenaline Autoinjector prescribing, there has been no obvious reduction in numbers of fatal anaphylaxis cases. Animal and human studies suggest intravenous adrenaline infusion, with appropriate fluid resuscitation, prevents fatal anaphylaxis. Current Adrenaline Autoinjectors may have little impact on rates of fatal anaphylaxis due to a lack of sustained and sufficient plasma adrenaline concentration.
Anaphylaxis Management in Paediatric Patients Undergoing Milk Oral Immunotherapy
-  9 October 2024
Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study
- Clinical & Experimental Allergy
-  337-352
-  8 February 2023
From trained immunity in allergy to trained immunity-based allergen vaccines
- Clinical & Experimental Allergy
-  145-155
-  9 December 2022
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective
- Clinical & Experimental Allergy
-  156-172
-  18 January 2023
Population prevalence of allergic bronchopulmonary aspergillosis in asthma: An epidemiological study of 43,261 participants from North India
- Clinical & Experimental Allergy
-  777-780
-  21 February 2023
The impact of prenatal dog keeping on infant gut microbiota development
- Clinical & Experimental Allergy
-  833-845
-  14 March 2023
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series
- Clinical & Experimental Allergy
-  586-589
-  16 March 2023
Oral immunotherapy using boiled peanuts for treating peanut allergy: An open‐label, single‐arm trial
- Clinical & Experimental Allergy
-  327-336
-  11 January 2023
Epigenome alterations in food allergy: A systematic review of candidate gene and epigenome-wide association studies
- Clinical & Experimental Allergy
-  259-275
-  9 February 2023
Safety and effectiveness of a milk ladder for managing children with IgE-mediated milk allergy
- Clinical & Experimental Allergy
-  61-63
-  9 November 2023
Allergic diseases as risk factors for Long-COVID symptoms: Systematic review of prospective cohort studies
- Clinical & Experimental Allergy
-  1162-1176
-  8 November 2023
BabyBathe study protocol: A randomised controlled feasibility trial to change baby bathing practice during the first months of life
- Clinical & Experimental Allergy
-  353-355
-  10 March 2024
Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study
- Clinical & Experimental Allergy
-  337-352
-  8 February 2023
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series
- Clinical & Experimental Allergy
-  586-589
-  16 March 2023
Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies
- Clinical & Experimental Allergy
-  582-585
-  13 February 2023
Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps
- Clinical & Experimental Allergy
-  11-20
-  2 January 2024
Management of Refractory Anaphylaxis: An Overview of Current Guidelines
- Clinical & Experimental Allergy
-  470-488
-  12 June 2024
Timing of complementary feeding for early childhood allergy prevention: An overview of systematic reviews
- Clinical & Experimental Allergy
-  1243-1255
-  1 October 2023
Effectiveness of FeNO-guided treatment in adult asthma patients: A systematic review and meta-analysis
- Clinical & Experimental Allergy
-  798-808
-  9 June 2023
From trained immunity in allergy to trained immunity-based allergen vaccines
- Clinical & Experimental Allergy
-  145-155
-  9 December 2022